Costs and benefits of non-invasive fetal RhD determination.

Teitelbaum, L; Metcalfe, A; Clarke, G; Parboosingh, J S; Wilson, R D; Johnson, J M

Teitelbaum, L; Metcalfe, A; Clarke, G; Parboosingh, J S; Wilson, R D; Johnson, J M.

Affiliation

Teitelbaum L; Department of Obstetrics and Gynecology, University of Calgary, Calgary, Alberta, Canada.

Ultrasound Obstet Gynecol ; 45(1): 84-8, 2015 Jan.

Article in En | MEDLINE | ID: mdl-25380024

Subject(s)

DNA/blood; Pregnancy Complications, Hematologic/prevention & control; Rh Isoimmunization/prevention & control; Rho(D) Immune Globulin/therapeutic use; Adult; Canada; Cell-Free System; Cost-Benefit Analysis; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Hematologic/economics; Program Evaluation; Rh Isoimmunization/economics; Rh-Hr Blood-Group System; Rho(D) Immune Globulin/economics

Key words

antenatal anti-RhD prophylaxis; cell-free fetal DNA; cost; fetal RhD determination; non-invasive prenatal testing

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Hematologic / Rh Isoimmunization / DNA / Rho(D) Immune Globulin Type of study: Evaluation_studies / Health_economic_evaluation / Prognostic_studies Limits: Adult / Female / Humans / Newborn / Pregnancy Country/Region as subject: America do norte Language: En Journal: Ultrasound Obstet Gynecol Journal subject: DIAGNOSTICO POR IMAGEM / GINECOLOGIA / OBSTETRICIA Year: 2015 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google